{"disease":{"id":"ophthalmic-solutions","name":"ophthalmic solutions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03198000","title":"A Study to Evaluate the Efficacy of Investigational OTC Eye Drops","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Johnson & Johnson Consumer Inc. (J&JCI)","has_results":true},{"nct_id":"NCT03591874","title":"Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":59,"lead_sponsor_name":"Ocugen","has_results":true},{"nct_id":"NCT05936489","title":"Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"LENZ Therapeutics, Inc","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}